CEBPB and AL amyloidosis: After silencing C/EBPβ in multiple myeloma cell lines and primary multiple myeloma cells, cell proliferation was strongly inhibited, which was involved in the regulatory network of transcription factors essential for plasma cell differentiation, growth, and proliferation [18].